Affirm Holdings, Inc. Share Price Target ‘$36.72’, now 11.2% Upside Potential

DirectorsTalk Interviews

Affirm Holdings, Inc. with ticker code (AFRM) have now 15 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The target price High/Low ranges between $65.00 and $20.00 calculating the mean target share price we have $36.72. (at the time of writing). Now with the previous closing price of $33.03 this now indicates there is a potential upside of 11.2%. Also worth taking note is the 50 day moving average now sits at $33.77 while the 200 day moving average is $31.11. The company has a market capitalization of 9.98B. The stock price is currently at: $32.28 USD

The potential market cap would be $11,093,324,747 based on the market consensus.

The company has a dividend yield of 0.89%. Other points of data to note are a P/E ratio of -, revenue per share of $6.90 and a -5.8% return on assets.

Affirm Holdings, Inc. provides a platform for digital and mobile-first commerce. The Company’s platform comprises three elements: point-of-sale payment solutions for consumers, merchant commerce solutions, and a consumer-focused app. Its point-of-sale solutions allow consumers to pay for purchases in fixed amounts without deferred interest, late fees, or penalties. Its merchant commerce solutions offer commerce enablement, demand generation, and customer acquisition tools. Its consumer-focused app provides Affirm products, which consumers can use to manage payments, open a high-yield savings account, and access a personalized marketplace. The Company’s platform provides consumer and merchant features. Its consumer features include checkout, consumer borrowing, virtual card, affirm app and marketplace and Affirm debit+ card. Its merchant features include affirm at Checkout, merchant dashboard, analytics, client success support, affirm app, and returns management, among others.

Share on:

Latest Company News

Meren Energy begins trading on OTCQX Market

Meren Energy Inc. has announced that its common shares are now trading on the OTCQX Best Market in the United States under the ticker symbol MRNFF.

HUTCHMED unveils next-generation ATTC Platform and key R&D advances

HUTCHMED (China) Limited has introduced its next-generation Antibody-Targeted Therapy Conjugate (ATTC) platform and shared major pipeline updates at its 2025 R&D event.

Cerillion to announce FY2025 results on 24 November

Cerillion plc will release its final results for the year ended 30 September 2025 on Monday, 24 November 2025.

Aptamer Group reports strong FY2025 growth and expands Optimer® portfolio

Aptamer Group delivered strong progress in FY2025, achieving a 40% revenue increase and expanding its portfolio of licensable Optimer® assets from four to eleven.

MHA reports 13% revenue growth and confirms full-year outlook

MHA has announced a strong first half for FY26, with revenue rising 13% to £121.3 million and performance in line with market expectations.

Thor Energy advances HY-Range hydrogen and helium exploration

Thor Energy has reported a strategically significant quarter ending September 2025, marked by major progress at its HY-Range hydrogen and helium project in South Australia. The company recorded hydrogen values

    Search

    Search